This formulation combines enteric-coated Rabeprazole Sodium with sustained-release Levosulpiride, intended for management of gastroesophageal reflux and related motility disorders.

Each unit of this PPI prokinetic combination capsule contains Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release), formulated in capsules form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating acid reflux and motility disorder medication for their regional markets.

Used in the management of acid-peptic and gastric motility disorders as directed by a physician. Suitable for supply to pharmacies, gastroenterology clinics, and hospitals.

Supplied in 10x10 blister strips, designed to preserve capsule integrity during international export. The 10x10 Capsules configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing enteric-coated levosulpiride rabeprazole formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying PPI prokinetic combination capsule to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: It contains Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release), manufactured to Indian Pharmacopoeia (IP) standards in capsules form.

Q: What pack sizes are available for Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: This product is supplied in 10x10 Capsules export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr is manufactured and supplied by CD&M Remedies, under product code 1017.

Q: Which product category does Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr belong to?
A: It falls under the Gastrointestinal Medication (PPI + Prokinetic Combination) category, intended for B2B pharmaceutical buyers and importers.